Literature DB >> 31983770

Ischemic Stroke Symptoms After Warfarin Reversal With 4-Factor Prothrombin Complex Concentrate Case Report.

Laura Carson1, John E Price1.   

Abstract

Objective: An 83-year-old woman with atrial fibrillation on chronic warfarin therapy was given 4-factor prothrombin complex concentrate to reverse her warfarin for surgery. She had fallen off a step stool at home and fractured her left wrist which initially the surgeon was going to repair surgically. Method: The day after she received 4-factor prothrombin complex concentrate, she developed stroke-like symptoms, National Institutes of Health Stroke Scale (NIHSS) was 14, and met criteria for tissue plasminogen activator (tPA) administration. Tissue plasminogen activator was administered and she was transferred to the intensive care unit (ICU), per hospital protocol.
Results: She remained in the ICU for 24 hours for follow-up and monitoring. Her warfarin was restarted and bridged with enoxaparin. She was not a candidate for antiplatelet therapy due to her history of a gastrointestinal (GI) bleed.
Conclusion: At discharge, she had no residual effects from her stroke-like symptoms and a magnetic resonance imaging (MRI) of her brain was negative for an acute cerebrovascular accident (CVA).
© The Author(s) 2019.

Entities:  

Keywords:  CQI; adverse drug reactions; anticoagulants; blood products; critical care; medication safety; physician prescribing

Year:  2019        PMID: 31983770      PMCID: PMC6961148          DOI: 10.1177/0018578718823739

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  9 in total

1.  Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  James D Douketis; Alex C Spyropoulos; Frederick A Spencer; Michael Mayr; Amir K Jaffer; Mark H Eckman; Andrew S Dunn; Regina Kunz
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  Bringing diagnosis into the quality and safety equations.

Authors:  Mark L Graber; Robert M Wachter; Christine K Cassel
Journal:  JAMA       Date:  2012-09-26       Impact factor: 56.272

Review 3.  Overconfidence as a cause of diagnostic error in medicine.

Authors:  Eta S Berner; Mark L Graber
Journal:  Am J Med       Date:  2008-05       Impact factor: 4.965

4.  The costs of fatal and non-fatal falls among older adults.

Authors:  J A Stevens; P S Corso; E A Finkelstein; T R Miller
Journal:  Inj Prev       Date:  2006-10       Impact factor: 2.399

5.  Interventional spine and pain procedures in patients on antiplatelet and anticoagulant medications: guidelines from the American Society of Regional Anesthesia and Pain Medicine, the European Society of Regional Anaesthesia and Pain Therapy, the American Academy of Pain Medicine, the International Neuromodulation Society, the North American Neuromodulation Society, and the World Institute of Pain.

Authors:  Samer Narouze; Honorio T Benzon; David A Provenzano; Asokumar Buvanendran; José De Andres; Timothy R Deer; Richard Rauck; Marc A Huntoon
Journal:  Reg Anesth Pain Med       Date:  2015 May-Jun       Impact factor: 6.288

6.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

7.  Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference?

Authors:  Bellal Joseph; Hassan Aziz; Viraj Pandit; Daniel Hays; Narong Kulvatunyou; Zeeshan Yousuf; Andrew Tang; Terence O'Keeffe; Donald Green; Randall S Friese; Peter Rhee
Journal:  World J Surg       Date:  2014-08       Impact factor: 3.352

8.  Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.

Authors:  Nathan P Clark; Daniel M Witt; Loren E Davies; Edward M Saito; Kathleen H McCool; James D Douketis; Kelli R Metz; Thomas Delate
Journal:  JAMA Intern Med       Date:  2015-07       Impact factor: 21.873

Review 9.  Long-term safety and efficacy of a pasteurized nanofiltrated prothrombin complex concentrate (Beriplex P/N): a pharmacovigilance study.

Authors:  A A Hanke; C Joch; K Görlinger
Journal:  Br J Anaesth       Date:  2013-01-18       Impact factor: 9.166

  9 in total
  1 in total

1.  Stroke Symptoms in a Patient on 4-Factor Prothrombin Complex.

Authors:  Ajay Kumar Mishra; Kamal Kant Sahu; Amos Lal
Journal:  Hosp Pharm       Date:  2020-03-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.